Effect of the Hydroethanolic Extract of <i>Bixa orellana</i> Linn (Bixaceae) Leaves on Castor Oil-Induced Diarrhea in Swiss Albino Mice

Fokam Tagne, Michel Archange; Akaou, Hypolyte; Noubissi, Paul Aimé; Foyet Fondjo, Angèle; Rékabi, Yaouke; Wambe, Henri; Kamgang, René; Essame Oyono, Jean-Louis

doi:https://doi.org/10.1155/2019/6963548

Gastroenterology Research and Practice

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusion Data Availability Conflicts of Interest Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2019 | Article ID 6963548 | https://doi.org/10.1155/2019/6963548

Effect of the Hydroethanolic Extract of Bixa orellana Linn (Bixaceae) Leaves on Castor Oil-Induced Diarrhea in Swiss Albino Mice

Michel Archange Fokam Tagne,¹Hypolyte Akaou,¹Paul Aimé Noubissi,²Angèle Foyet Fondjo,³Yaouke Rékabi,¹Henri Wambe,⁴René Kamgang,^5,6and Jean-Louis Essame Oyono⁶

Academic Editor: Lukas J.A.C. Hawinkels

Received12 Jul 2019

Revised16 Sept 2019

Accepted03 Oct 2019

Published01 Dec 2019

Abstract

Objective. The treatment of diarrheal diseases is a serious problem in developing countries, where population generally uses medicinal plants. The leaves of Bixa orellana have been reported to be traditionally used in the treatment of diarrhea by local people in the district of Khulna in Bangladesh. The aim of this study was to investigate the effects of the hydroethanolic extract of Bixa orellana leaves on castor oil-induced diarrhea in mice. Methods. The powder of the leaves of Bixa orellana was macerated in ethanol/water mixture (20/80) for 48 hours and then filtered. The filtrate obtained was lyophilized, and the solutions to be administered to the animals were prepared. To induce diarrhea, animals orally received castor oil (1 mL/100 g bw). To determine the effective doses, each mouse received, 30 minutes after the administration of castor oil, one of the single oral doses of hydroethanolic extract of Bixa orellana leaves: 0, 25, 50, 100, and 200 mg/kg bw. The mass, number, and frequency of stool diarrhea were measured and recorded per hour for five hours. The effect of the hydroethanolic extract of Bixa orellana leaves on the intestinal transit was evaluated by measuring the distance traveled by the charcoal meal in thirty minutes. The effects of the aqueous extract of hydroethanolic extract of Bixa orellana leaves on intestinal secretion were evaluated by measuring the volume of the intestinal content and by dosing the electrolytes (Na⁺, K⁺, and Cl^-) in the intestinal content by the colorimetric method. Results. The extract produced significant () decreases, respectively, 35.52%, 54.47%, 74.80%, and 87.80% in the severity of diarrhea. The extract at 100 and 200 mg/kg bw showed a significant () decrease of castor oil-induced enteropooling (61.08% and 65.41%), and only the 200 mg/kg bw exhibited significant () reduction on intestinal transit (24.46%) as compared to standard drug. Conclusions. The hydroethanolic extract was found to be effective against castor oil-induced diarrhea in experimental mice at 50, 100, and 200 mg/kg bw which provides evidence that could justify its traditional use.

1. Introduction

In developing countries, diarrheal diseases are a major cause of suffering and millions of deaths every year. These diseases represent the most serious problem in these countries, affecting more children and are considered the second leading cause of death in children under five [1, 2]. Diarrhea most of the time refers to a disease and sometimes is a symptom of other disease conditions. It is associated with infectious agents (viral, bacterial, and fungus infection), food poisoning, and other disease conditions of the gastrointestinal disorder, characterized by an increase in stool frequency [2]. Diarrhea is incontinence and a fecal urgency associated with an imbalance between the mechanisms of intestinal absorption and secretion. This imbalance usually results in excessive loss of body fluids and electrolytes in the stool and is often accompanied by intestinal hypermotility [2]. The major categories of diarrhea most commonly encountered are secretory diarrhea with an , osmotic diarrhea with an , and motor diarrhea resulting from decreased digestive tract diameter, water malabsorption, and increased intestinal peristalsis [3]. The use of synthetic drugs such as diphenoxylate, atropine maleate, kaolin, pectin, antibiotics, and oral rehydration solutions in the treatment of diarrhea is often associated with many problems such as accessibility, high cost of drugs, and the multiresistance of microorganisms. These problems related to modern medicine are driving many people in developing countries to turn to local traditional medicine that uses medicinal plants in the treatment of these diarrheal diseases [4]. In the world, medicinal plants are a source of major compounds used as drugs or therapeutic agents [5] and many of which are effective. In many countries, medicinal plants are alternative sources of drugs for the majority of the population who do not have access to conventional medicine. The lack of less toxic synthetic drugs available to fight common conditions such as diarrhea has prompted many people to turn to herbal remedies that can relieve the disease or permanently control the secretory process leading to diarrhea [6].

Several medicinal plants have already scientifically shown their efficiencies with less harm in the treatment of diarrhea. We can mention among others, Oxalis barrelieri [7, 8], Crinum jagus [9, 10], Anogeissus leiocarpus [11], Euphorbia scordifolia [12, 13], and Bixa orellana [14]. Bixa orellana is widely used in traditional medicine for the prevention and treatment of a large number of diseases such as headaches, blood disorders, gonorrhea, fever, epilepsy, dysentery, and jaundice [15]. People in Bangladesh use the leaves of this plant to treat diarrhea, insomnia, and skin diseases [16]. The methanolic extract of Bixa orellana showed maximal antidiarrheal activity (85%) at 500 mg/kg [16]. In Cameroon, Bixa orellana is widely available in Ngaoundere (Adamawa region) and is traditionally used (maceration of the leaves in the white wine of raffia or decoction) by this population in the treatment of joint pain, jaundice, fever, and abdominal pain. Given that the effectiveness of a plant extract depends on the location, the season, and the harvesting time off, as well as the mode of extraction of the plant, the main objective of this work was to evaluate the antidiarrheal properties of the hydroethanolic extract of Bixa orellana leaves to prove its effectiveness in the treatment of diarrheal diseases in Cameroon.

2. Materials and Methods

2.1. Plant Material

The fresh leaves of Bixa orellana were harvested at the Ngaoundere (Adamawa region of Cameroon) University campus in July 2018 between 8 and 10 am. The plant was then identified at the Cameroon National Herbarium in comparison with the material of Surville N. No. 349 of the specimen in the Herbier collection No. 14099/SRF.Cam.

The leaves of Bixa orellana were harvested and thoroughly washed in water to remove dirt. These leaves were dried in the shade at room temperature and then ground to a dried powder. Two hundred grams (200 g) of this powder was macerated in 2 L of ethanol/water mixture (20/80) for 72 hours. After the maceration period, the macerated powder was then pressed and the residue was remacerated. Plant extract solutions obtained were then filtered using the Whatman No.1 filter paper. The filtrate was aliquoted in bottles, frozen at -35°C, and then lyophilized with a freeze dryer (CHRIST, ALPHA 1-2.LD.plus) to obtain 27.50 g of crude extract, a yield of 13.75%. Prior to oral administration, the extract was dissolved in distilled water so that each animal received no more than 10 mL/kg of body weight.

2.2. Preliminary Phytochemical Screening Test

The qualitative phytochemical screening of the hydroethanolic extract of Bixa orellana was performed using the following chemical reagents and tests [17–19]: Dragendorff and Mayer reagents for the determination of alkaloids, ferric chloride (FeCl₃) and K₃Fe[(CN)₆] for tannins, Liebermann-Burchard test for terpenoid and sterol, Shinoda test for flavonoids, frothing test for saponins, Molisch test for polysaccharides, UV lamps for coumarins, and Borntrager’s test for anthraquinones.

2.3. Experimental Animals

Young, healthy Swiss Albino mice, 12 weeks old, weighing between 20 and 25 g, of either sex, obtained from the animal house of the Faculty of Sciences of the University of Ngaoundere, Cameroon, were used for this work. Animal housing and in vivo experiments were done according to the guidelines of the European Union on Animal Care (CEE Council 86/609) [20] that were adopted in Cameroon by the Institutional Committee of the Ministry of Scientific Research and Innovation. The mice were housed in polyethylene cages (5 animals per cage) and acclimated for one week under the environmental conditions of the laboratory prior to the study. During the acclimation period, the animals had free access to food and water.

2.4. Activity of the Hydroethanolic Extract of Bixa orellana Leaves on Castor Oil-Induced Diarrhea in Mice

Six groups of five mice each were fasted for 18 h with free access to water. To induce diarrhea, castor oil (0.5 mL) was orally administered to all mice [21]. Thirty minutes after castor oil administration, the first group (diarrheal control: DC) received distilled water (10 mL/kg bw), the second group received the reference drug, Loperamide (ELDOPER, Micro Labs, 92, sipcot, Hosur-635126, India) 5 mg/kg bw, while the other four (4) groups received one of the Bixa orellana hydroethanolic extract doses: 25, 50, 100, or 200 mg/kg bw by oral route. After these treatments, each mouse was individually placed in a metabolic cage lined with previously weighed filter paper. These filter papers were changed every hour for 5 h [22]. During each hour, total stool mass, diarrhea stool mass, total stool count, and the number of diarrheal stool wet feces were recorded. The percentage inhibition of diarrhea and the stool emission frequency (SEF) were calculated as follows [11]: where is the inhibition; SMDC is the stool mass of diarrheal control; SMDT is the stool mass of diarrheal test.

2.5. Activity of the Hydroethanolic Extract of Bixa orellana Leaves on Intestinal Transit in Mice

Five groups of five normal mice each were fasted for 18 h with free access to water. The normal control group (NC) received distilled water (10 mL/kg bw). The second group (AT0.3) received the standard drug: atropine sulfate (Gland Pharma, Pally, Dundigal Post, Hyderabad, India) 0.3 mg/kg bw i.p. The three other groups received one of the Bixa orellana leaf hydroethanolic extract doses: 50 mg/kg (HEBo50), 100 mg/kg (HEBo100), and 200 mg/kg (HEBo200). Thirty minutes after these treatments, each mouse received 1 mL of charcoal meal (5% activated charcoal by 5% gum acacia), and 30 minutes later, the animals were sacrificed by cervical dislocation. The abdomen of each animal was opened, and the intestine was removed. The total distance of the small intestine and the distance traveled by the charcoal meal in the intestine were measured with a tape measure and then expressed as a percentage of the total distance traveled from the pylorus to the caecum [23]. The peristaltic index (PI) was calculated as follows [11]: where PI is the peristaltic index, CCL is the charcoal covered length, and ITL is the intestine total length.

2.6. Activity of the Hydroethanolic Extract of Bixa orellana Leaves on Castor Oil-Induced Enteropooling in Mice

Six groups of five mice each were fasted for 18 h with free access to water. The normal control (NC) group received distilled water (10 mL/kg bw). The other five groups received castor oil (0.5 mL). Thirty minutes after castor oil administration, the diarrhea control (DC) group received distilled water (10 mL/kg bw), the third group (Lop5) received the reference drug, Loperamide (ELDOPER, Micro Labs, 92, sipcot, Hosur-635126, India) 5 mg/kg bw, while the other three (03) groups received one of the Bixa orellana hydroethanolic extract doses: 50 mg/kg bw (HEBo50), 100 mg/kg bw (HEBo100), or 200 mg/kg bw (HEBo200) by oral route. One hour later, the mice were sacrificed, the small intestine removed and weighed with its content. The contents of the small intestine were further emptied into a graduated tube, its volume measured and the emptied small intestine reweighed [23, 24]. The intestinal content was used for the determination of electrolytes (sodium, potassium, and chloride) levels.

2.7. Electrolyte Assessment and Stool Osmotic Gap

2.7.1. Determination of Chloride Ions

The chloride ions were assayed by the colorimetric method using the kit (SGM Italia-Via Pindaro 28C-Roma). The chloride ions react with mercury thiocyanate-releasing thiocyanate ions which form with trivalent iron a colored compound whose intensity of color is proportional to the chloride concentration.

One thousand microliters (1000 μL) of the reagent was put in all the tubes. We then added 10 μL of distilled water in the white tube, 10 μL of standard solution (100 mEq/L) in the standard tube, and 10 μL of samples in the test tubes. Each mixture was incubated for five (5) minutes at 37°C in a water bath, and then, the optical densities (OD) were read with the spectrophotometer (UNICO© ULTRA VIOLET) at 480 nm. The concentration of the chloride ions in each tube was determined by the following formula: where [Cl⁻] is the concentration of chloride ions in the intestine content; Abs T is the absorbance of the test tube; Abs S is the absorbance of the standard tube; [S] is the standard concentration of chloride ions (100 mEq/L).

2.7.2. Determination of Sodium Ions

The sodium ions were assayed by colorimetric method using the kit (LIQUIZYME SODIUM, BEACON DIAGNOSTICS PVT. LTD., 424 New GIDC, Kabilpore, Navsari-396 424, India). Sodium ions react with the selective chromogen and produce a chromophore whose absorbance is directly proportional to the concentration of sodium in the sample.

Five hundred microliters (500 μL) of the reagent was put in all the tubes. We added 10 μL of distilled water in the blank tube, 10 μL of standard solution (150 mEq/L) in the standard tube, and 10 μL of samples in the test tubes. Each mixture was incubated in a water bath for five (5) minutes at 37°C, and then, the absorbance was read at 630 nm with a spectrophotometer (UNICO© ULTRA VIOLET). The concentration of sodium ions in each tube was determined by the following formula: where [Na⁺] is the concentration of sodium ions in the intestine content; Abs T is the absorbance of the test tube; Abs S is the absorbance of the standard tube; [S] is the standard concentration of chloride ions (150 mEq/L).

2.7.3. Determination of Potassium Ions

The potassium ions were assayed by colorimetric method using the kit (LIQUIZYME POTASSIUM, BEACON DIAGNOSTICS PVT. LTD., 424 New GIDC, Kabilpore, Navsari-396 424, India). The potassium ion reacts with tetraphenol in a specially prepared buffer to form a colloidal suspension. The amount of turbidity produced is directly proportional to the potassium concentration in the sample.

Five hundred microliters (500 μL) of the reagent was put in all the tubes. We then added 20 μL of distilled water in the white tube, 20 μL of standard solution in the standard tube, and 20 μL of samples in the test tubes. Each mixture was incubated in a water bath for five (5) minutes at 37°C, and the absorbance of the contents of each tube was read at 630 nm with the spectrophotometer (UNICO ULTRA VIOLET). The concentration of potassium ions in each tube was determined by the following formula: where [K⁺] is the concentration of potassium ions in the intestine content; Abs T is the absorbance of the test tube; Abs S is the absorbance of the standard tube; [S] is the standard concentration of chloride ions (5 mEq/L).

2.7.4. Determination of Stool Osmotic Gap (SOG)

The stool osmotic gap was calculated according to the formula [25] where [Na⁺] is the concentration of sodium ions in the intestine content, and [K⁺] is the concentration of potassium ions in the intestine content.

2.8. Statistical Analysis

Data were expressed as (). Data were analyzed by one-way ANOVA followed by Dunnett’s -test using computerized GraphPad InStat (DATASET1.ISD). Values were considered significant at in comparison with the control.

3. Results

3.1. Phytochemical Compounds of the Hydroethanolic Extract of Bixa orellana Leaves

The phytochemical screening of the hydroethanolic extract of Bixa orellana revealed the presence of terpenes, flavonoids, tannins, coumarins, and saponins. However, the absence of alkaloids and anthraquinones was noted (Table 1).

3.2. Antidiarrheal Activity of Hydroethanolic Extract of Bixa orellana Leaves

A few minutes after castor oil administration, mice became less mobile and folded on themselves with erect hairs. The first diarrheal stools appeared generally on the first and rarely at the second hour in the treated mice. Five (5) hours after the administration of castor oil, diarrheal controls emitted and of diarrheal stools. These diarrheal stools significantly () decreased in animals treated with the hydroethanolic extract of Bixa orellana leaves at 50 mg/kg (HEBo50), 100 mg/kg (HEBo100), and 200 mg/kg (HEBo200). The inhibition rate of diarrhea was 84.00%, 32.00%, 56.00%, 76.00%, and 88.00%, respectively, in mice treated with Loperamide 5 mg/kg bw (Lop5), Bixa orellana leaf hydroethanolic extract at 25 mg/kg (HEBo25), 50 mg/kg (HEBo50), 100 mg/kg (HEBo100), and 200 mg/kg (HEBo200). The frequency of stool emission was, respectively, 3.0, 0.6, 1.8, 0.8, 0.6, and 0.2/h for diarrheal control, Lop5, HEBo25, HEBo50, HEBo100, and HEBo200 (Table 2).

3.3. Effect of the Hydroethanolic Extract of Bixa orellana Leaves on Intestinal Transit

The progress of charcoal meal in the gastrointestinal tract was , , , , and , respectively, in the normal control (NC), the group treated with atropine sulfate 0.3 mg/kg (AT0.3), and the groups treated with the Bixa orellana leaf hydroethanolic extract at 50 mg/kg (HEBo50), 100 mg/kg (HEBo100), and 200 mg/kg (HEBo200). The inhibition of intestinal transit was 37.04%, 27.75%, 33.54%, and 37.94%, respectively (Table 3).

3.4. Effect of the Hydroethanolic Extract of Bixa orellana Leaves on Castor Oil-Induced Enteropooling

The difference in mass between the untrimmed bowel and the emptied bowel was , , , , , and , respectively, in the diarrheal control (DC), the normal control (NC), the treated group with Loperamide 5 mg/kg (Lop5), and the test groups treated with Bixa orellana leaf hydroethanolic extract at 50 mg/kg (HEBo50), 100 mg/kg (HEBo100), and 200 mg/kg (HEBo200) (Table 4).

The volume of intestinal contents was , , , , , and , respectively, in the normal control (NC), the diarrheal control (DC), the Loperamide-treated group, 5 mg/kg (Lop5), and the test groups treated with Bixa orellana hydroethanolic extract at 50 mg/kg (HEBo50), 100 mg/kg (HEBo100), and 200 mg/kg (HEBo200). The inhibition of secretion was 35.14%, 61.08%, 65.41%, and 62.16%, respectively (Figure 1).

3.5. Effect of the Hydroethanolic Extract of Bixa orellana Leaves on Electrolyte Concentration and Stool Osmotic Gap

Concentrations of chloride ions were in diarrheal controls and in normal control. Compared to diarrheal controls, these values significantly decreased () in treated animals and were , , , and , respectively, for animals treated with Loperamide or with Bixa orellana leaf hydroethanolic extract at 50 mg/kg, 100 mg/kg, and 200 mg/kg. Sodium ion concentrations in animals treated with Bixa orellana leaf hydroethanolic extract or Loperamide were significantly () low compared to diarrhea control () and were, respectively, , , and at 50, 100, and 200 mg/kg or for Loperamide 5 mg/kg. Potassium ion concentrations were , , , , , and , respectively, in normal control, diarrheal control, and in animals treated with Loperamide or with hydroethanolic extract of Bixa orellana leaves at 50 mg/kg, 100 mg/kg, and 200 mg/kg (Table 5).

In diarrheal control, stool osmotic gap was less than 50 mEq/L and was 19.30 mEq/L. In all other animals, the stool osmotic gap was greater than 50 mEq/L and was 63.30 mEq/L, 61.58 mEq/L, 54.58 mEq/L, 55.10 mEq/L, and 57.30 mEq/L, respectively, in normal control and in animals treated with Loperamide or with Bixa orellana leaf hydroethanolic extract at 50, 100, and 200 mg/kg (Figure 2).

4. Discussion

The leaves of Bixa orellana have been reported to be traditionally used in the treatment of diarrhea by local people in the district of Khulna in Bangladesh, and scientifically, the methanolic extract of its leaves showed to have a maximum antidiarrheal activity at 500 mg/kg [16]. In this study, the hydroethanolic extract of leaves of B. orellana was prepared to investigate its effects on castor oil-induced diarrhea.

Depending on its etiology, diarrhea may be characterized by increased secretion of electrolytes (secretory diarrhea), increased luminal osmolality (osmotic diarrhea), decreased electrolyte absorption, and/or increased intestinal motility responsible for reduced transit time. Many antidiarrheal agents can therefore act by increasing the transit time by inhibiting gastrointestinal motility, inhibiting intestinal secretions, and/or increasing the intestinal absorption of water and electrolytes. Laxatives such as castor oil induce diarrhea by increased motility and/or gastrointestinal secretions via its active ingredient, the ricinoleic acid. Ricinoleic acid modifies the permeability of the intestinal mucosa to electrolytes [26] by inhibiting the intestinal Na⁺/K⁺ ATPase activity [8] and stimulating the biosynthesis and release of the endogenous prostaglandins responsible for diarrhea [27]. In this study, the hydroethanolic extract of Bixa orellana leaves at 200 mg/kg bw significantly and maximumly (88%) reduced the amount and frequency of castor oil-induced diarrheal stools in mice, unlike the methanolic extract which showed maximal inhibition (85%) at 500 mg/kg. Our extract could act by inhibiting one or more of the mechanisms of induction of diarrhea by castor oil.

Bixa orellana extract (200 mg/kg bw) significantly inhibited intestinal peristalsis almost as the reference drug, atropine. Atropine is a competitive antagonist of acetylcholine muscarinic receptor [28] located on the intestinal smooth muscle. The activation of these receptors induces the production of the second messengers IP₃ and Diacyl glycerol (DAG) which are responsible for the increase of cytosolic calcium and smooth muscle contraction [11, 29, 30]. Like in the ethanolic extract of Bixa Orellana [14], phytochemical studies of the hydroethanolic extract revealed the presence of flavonoids, triterpenes, and tannins. These molecules would act either by blocking muscarinic receptors or by activating the opioid μ receptors located on the smooth intestinal muscle and thus reducing intestinal peristalsis [31–35].

Castor oil induced secretory diarrhea in mice because the osmotic gap was less than 50 mEq/L [25, 36]. The hydroethanolic extract of Bixa orellana leaves at 100 and 200 mg/kg bw reduced the volume and mass of the intestinal contents and maintained normal the value of the stool osmotic gap (greater than 50 mEq/L) almost like the reference drug, Loperamide. The antidiarrheal action of Loperamide can be mediated by an antisecretory mechanism. Loperamide is an opioid that affects intestinal absorption and inhibits its secretion by acting on the δ receptor. The antisecretory effect of Loperamide can be explained by the inhibition of the mechanisms leading to the synthesis of cAMP and cGMP, by the activation of Na⁺/K⁺ ATPase [37] or by stimulating cotransport of sodium chloride from the intestine and inhibiting calmodulin [25, 36]. In the presence of Mg²⁺ ions, the Na⁺/K⁺ ATPase catalyzes the release of Na⁺ and the entry of two K⁺ ions. The Na⁺/K⁺ ATPase is expressed in all intestinal epithelial cells and acts to maintain a low intracellular concentration of Na⁺ and a high intracellular concentration of K⁺ [38]. The inactivation of the Na⁺/K⁺ ATPase pump with ricinoleic acid inhibits all these active transport mechanisms in the intestine. This could indicate that the effect of the hydroethanolic extract of Bixa orellana leaves could be acted by an antisecretory mechanism similar to that of Loperamide by inhibiting the synthesis of cAMP and cGMP or by activating the Na⁺/K⁺ ATPase activity. These results could be explained by the presence in our hydroethanolic extract of antidiarrheal compounds such as flavonoids, tannins, terpenes, saponins, and sterols which are known for their antidiarrheal activities either as a transit inhibitor or as an antisecretory agent [31–34]. Indeed, it has been shown that flavonoids act through α₂-adrenergic and calcium systems to exert their inhibitory effect on intestinal functions [31].

5. Conclusion

The hydroethanolic extract of Bixa orellana leaves inhibited diarrhea, reduced stool frequency, and inhibited intestinal peristalsis as well as water and electrolyte secretions. These effects prove the antidiarrheal activity of the hydroethanolic extract of Bixa orellana leaves and would justify the use of this plant in the treatment of diarrheal diseases. The precise mechanisms of this hydroethanolic extract of Bixa orellana leaves, which are responsible for the antidiarrheal activity, would be clarified by further studies.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors of this work declare no conflict of interest.

Acknowledgments

The authors thank the Faculty of Science, University of Ngaoundere, Cameroon, for providing the necessary support for this study.

References

M. Khalilur Rahman, S. Barua, M. F. Islam et al., “Studies on the anti–diarrheal properties of leaf extract of Desmodium puchellum,” Asian Pacific Journal of Tropical Biomedicine, vol. 3, no. 8, pp. 639–643, 2013.
View at: Publisher Site | Google Scholar
S. O. Otimenyin and D. C. Uzochukwu, “Spasmolytic and antidiarrhea effects of the bark of Erythrina senegalensis and root of Kigelia Africana,” Asian Journal of Pharmaceutical and Clinical Research, vol. 3, no. 4, pp. 11–14, 2010.
View at: Google Scholar
K. Fine and L. Schiller, “AGA technical review on the evaluation and management of chronic diarrhea,” Gastroenterology, vol. 116, no. 6, pp. 1464–1486, 1999.
View at: Publisher Site | Google Scholar
H. R. Chitme, R. Chandra, and S. Kaushik, “Studies on anti-diarrheal activity of Calotropis gigantea R.BR. in experimental animals,” Journal of Pharmacy & Pharmaceutical Sciences, vol. 7, no. 1, pp. 70–75, 2004.
View at: Google Scholar
P. A. Akah, O. Nneto, and A. C. Ezike, “Medicinal plants used in the traditional treatment of peptic ulcer diseases: a case study of Napoleana vogelli Hook and Planch (Lecythidaceae),” Research Journal of Pharmacology, vol. 1, no. 3, pp. 67–74, 2007.
View at: Google Scholar
B. Ayinde and O. Owolabi, “Effects of the aqueous extract of Ficus capensis Thunb.(Moraceae) leaf on gastrointestinal motility,” Journal of Pharmacognosy and Phytotherapy, vol. 1, no. 3, pp. 31–35, 2009.
View at: Google Scholar
M. A. Fokam Tagne, P. A. Noubissi, G. O. Fankem, and R. Kamgang, “Effects of Oxalis barrelieri L. (Oxalidaceae) aqueous extract on diarrhea induced by Shigella dysenteriae type 1 in rats,” Health Science Reports, vol. 1, no. 2, article e20, 2018.
View at: Publisher Site | Google Scholar
M. A. Fokam Tagne, R. Kamgang, P. A. Noubissi, and J.-L. Essame Oyono, “Activity of Oxalis barrelieri aqueous extract on rat secretory diarrhea and intestine transit,” Journal of Applied Pharmaceutical Science, vol. 5, no. 1, pp. 058–062, 2015.
View at: Publisher Site | Google Scholar
P. A. Noubissi, M. A. Fokam Tagne, G. O. Fankem, J. Ngakou Mukam, H. Wambe, and R. Kamgang, “Effects of Crinum jagus water/ethanol extract on Shigella flexneri-induced diarrhea in rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2019, Article ID 9537603, 10 pages, 2019.
View at: Publisher Site | Google Scholar
P. A. Noubissi, C. Mvongo, M. A. Fokam Tagne, F. P. Manfo Tsague, G. O. Fankem, and R. Kamgang, “Antidiarrheal, antimicrobial and cytotoxic activities of Crinum Jagus extracts,” Journal of Physiology and Pharmacology Advances, vol. 6, no. 11, pp. 938–949, 2016.
View at: Publisher Site | Google Scholar
M. A. Fokam Tagne, Y. Rékabi, P. A. Noubissi et al., “Evaluation of antidiarrheal activity of aqueous leaf extract of Anogeissus leiocarpus on castor oil-induced diarrhea in rats,” American Journal of Biomedical Science & Research, vol. 3, no. 1, pp. 27–34, 2019.
View at: Publisher Site | Google Scholar
M. A. Fokam Tagne, P. A. Noubissi, and R. Kamgang, “Acute and subchronic oral toxicity studies of an ethanol/water extract of Euphorbia scordifolia Jacq (Euphorbiaceae) in mice and in rats,” International Journal of Pharmacology, Phytochemistry and Ethnomedicine, vol. 7, pp. 18–29, 2017.
View at: Publisher Site | Google Scholar
R. Kamgang, M. A. Fokam Tagne, H. Gonsu Kamga, P. A. Noubissi, M. C. Fonkoua, and J.-L. Essame Oyono, “Activity of aqueous ethanol extract of Euphorbia scordifolia on Shigella dysenteriae type 1-induced diarrhea in rats,” International Journal of Pharmaceutical Sciences and Drug Research, vol. 7, no. 1, pp. 40–45, 2015.
View at: Google Scholar
P. Gupta, “Bixa orellana: a review on phytochemistry, traditinal and pharmacological uses,” World Journal of Pharmaceutical Sciences, vol. 4, no. 3, pp. 500–510, 2016.
View at: Google Scholar
P. Srineeraja, “Pharmacological properties of Bixa Orellana–a review,” International Journal of Science and Research (IJSR), vol. 6, no. 7, pp. 751–755, 2017.
View at: Publisher Site | Google Scholar
J. A. Shilpi, M. Taufiq-Ur-Rahman, S. J. Uddin, M. S. Alam, S. K. Sadhu, and V. Seidel, “Preliminary pharmacological screening of Bixa orellana L. leaves,” Journal of Ethnopharmacology, vol. 108, no. 2, pp. 264–271, 2006.
View at: Publisher Site | Google Scholar
O. Longanga, A. Vercruysse, and A. Foriers, “Contribution to the ethnobotanical, phytochemical and pharmacological studies of traditionally used medicinal plant in the treatment of dysentery and diarrhea in Lomela area, Democratic Republic of Congo (DRC),” Journal of Ethnopharmacology, vol. 71, no. 3, pp. 411–423, 2000.
View at: Publisher Site | Google Scholar
A. Sofowora, Medicinal Plants and Traditional Medicine in Africa, Polugraphic venture, Ibadan, 1998.
G. Trease and W. Evans, Pharmacognosy, Sounders, Edinburgh, 1997.
J. Smith, F. van den Broek, J. C. Martorell et al., “Principles and practice in ethical review of animal experiments across Europe: summary of the report of a Felasa working group on ethical evaluation of animal experiments,” Laboratory Animals, vol. 41, no. 2, pp. 143–160, 2007.
View at: Publisher Site | Google Scholar
S. Doherty, “Inhibition of arachinodic acid release as the mechanism by which glucocorticoids inhibit endotoxin‐induced diarrhoea,” British Journal of Pharmacology, vol. 73, no. 2, pp. 549–554, 1981.
View at: Publisher Site | Google Scholar
S. Meite, J. D. N’guessan, C. Bahi, H. Yapi, A. J. Djaman, and F. Guede Guina, “Antidiarrheal activity of the ethyl acetate extract of Morinda morindoides in rats,” Tropical Journal of Pharmaceutical Research, vol. 8, no. 3, pp. 201–207, 2009.
View at: Publisher Site | Google Scholar
I. Ezeja, I. Ezeigbo, K. Madubuike et al., “Antidiarrheal activity of Pterocarpus erinaceus methanol leaf extract in experimentally–induced diarrhea,” Asian Pacific Journal of Tropical Medicine, vol. 5, no. 2, pp. 147–150, 2012.
View at: Publisher Site | Google Scholar
A. Maiti, S. Dewanjee, and S. C. Mandal, “In vivo evaluation of antidiarrhoeal activity of the seed of Swietenia macrophylla King (Meliaceae),” Tropical Journal of Pharmaceutical Research, vol. 6, no. 2, pp. 711–716, 2007.
View at: Publisher Site | Google Scholar
A. J. Eherer and J. S. Fordtran, “Fecal osmotic gap and pH in experimental diarrhea of various causes,” Gastroenterology, vol. 103, no. 2, pp. 545–551, 1992.
View at: Publisher Site | Google Scholar
P. Rawat, P. K. Singh, and V. Kumar, “Evidence based traditional anti-diarrheal medicinal plants and their phytocompounds,” Biomedicine and Pharmacotherapy, vol. 96, pp. 1453–1464, 2017.
View at: Publisher Site | Google Scholar
W. T. Tadesse, A. E. Hailu, A. E. Gurmu, and A. F. Mechesso, “Experimental assessment of antidiarrheal and antisecretory activity of 80% methanolic leaf extract of Zehneria scabra in mice,” BMC Complementary and Alternative Medicine, vol. 14, no. 1, pp. 460–468, 2014.
View at: Publisher Site | Google Scholar
F. Teixeira-Neto, W. McDonell, W. Black, W. Harris, and L. Grovum, “Effects of muscarinic receptor antagonists on acetylcholine-induced contractions of jejunal smooth muscle in horses,” Journal of Veterinary Pharmacology and Therapeutics, vol. 35, no. 4, pp. 313–318, 2012.
View at: Publisher Site | Google Scholar
K. N. Bitar, R. R. Gilmont, S. Raghavan, and S. Somara, “Chapter 17 - cellular physiology of gastrointestinal smooth muscle,” in Physiology of the Gastronintestinal Tract, J. D. W. L. R. Johnson, F. K. Ghishan, J. D. Kaunitz, J. L. Merchant, and H.d. M. Said, Eds., vol. 1, pp. 489–509, Elsevier Inc., 2012.
View at: Publisher Site | Google Scholar
M. M. Suleiman, B. B. Oyelowo, A. Abubakar, M. Mamman, and K. T. Bello, “A controlled study to investigate anti-diarrhoeal effect of the stem-bark fractions of Terminalia avicennioides in laboratory animal models,” International Journal of Veterinary Science and Medicine, vol. 5, no. 1, pp. 14–22, 2017.
View at: Publisher Site | Google Scholar
G. Di Carlo, G. Autore, A. A. Izzo et al., “Inhibition of intestinal motility and secretion by flavonoids in mice and rats : structure-activity relationships,” Journal of Pharmacy and Pharmacology, vol. 45, no. 12, pp. 1054–1059, 1993.
View at: Publisher Site | Google Scholar
G. Jalilzadeh-amin and M. Maham, “The application of 1, 8-cineole, a terpenoid oxide present in medicinal plants, inhibits castor oil-induced diarrhea in rats,” Pharmaceutical Biology, vol. 53, no. 4, pp. 594–599, 2015.
View at: Publisher Site | Google Scholar
Z. K. Labu, F. R. Laboni, M. A. Mamun, and M. S. I. Howlader, “Antidiarrhoeal activity and total tannin content of ethanolic leaf extract of Codiaeum variegatum,” Dhaka University Journal of Pharmaceutical Sciences, vol. 14, no. 1, pp. 87–90, 2015.
View at: Publisher Site | Google Scholar
V. N. Rao, F. A. Santos, T. T. Sobreira, M. F. Souza, C. L. Melo, and E. R. Silveira, “Investigations on the gastroprotective and antidiarrhoeal properties of ternatin, a tetramethoxyflavone from Egletes viscosa,” Planta Medica, vol. 63, no. 2, pp. 146–149, 1997.
View at: Publisher Site | Google Scholar
N. Venkatesan, V. Thiyagarajan, S. Narayanan et al., “Antidiarrheal potential of Asparagus racemous wild root extracts in laboratory animals,” Journal of Pharmacy and Pharmaceutical Sciences, vol. 8, no. 1, pp. 39–45, 2005.
View at: Google Scholar
S. Huijghebaert, F. Awouters, and G. N. J. Tytgat, “Racecadotril versus loperamide: antidiarrheal research revisited,” Digestive Diseases and Sciences, vol. 48, no. 2, pp. 239–250, 2003.
View at: Google Scholar
S. Hughes, N. B. Higgs, and L. A. Turnberg, “Antidiarrhoeal activity of loperamide : studies of its influence on ion transport across rabbit ileal mucosa in vitro,” Gut, vol. 23, no. 11, pp. 974–979, 1982.
View at: Publisher Site | Google Scholar
S. J. Keely, M. H. Montrose, and K. E. Barrett, “Electrolyte secretion and absorption : small intestine and colon,” in Textbook of Gastroenterology, T. Yamada, Ed., pp. 330–367, Blackwell, 2009.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2019 Michel Archange Fokam Tagne et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

2286

Downloads

1473

Citations